Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified

Ítems similars

• Clinician Referrals for Non-opioid Pain Care Following Discontinuation of Long-term Opioid Therapy Differ Based on Reasons for Discontinuation
  per: Lovejoy, Travis I., et al.
  Publicat: (2018)
• Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test
  per: Nugent, Shannon M., et al.
  Publicat: (2017)
• Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain
  per: McPherson, Sterling, et al.
  Publicat: (2018)
• Patients’ perceptions of the pathways linking chronic pain with problematic substance use
  per: Wyse, Jessica, et al.
  Publicat: (2021)
• Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain
  per: Morasco, Benjamin J., et al.
  Publicat: (2019)